APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for PNH

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs for PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025182 pages

Choose your research edition.

Industry ResearchDrugs for PNH Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for PNH Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Drugs for PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for PNH Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for PNH Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Drugs for PNH market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs for PNH include Alexion Pharmaceuticals, Amgen, Apellis Pharmaceuticals, Roche, Novartis and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs for PNH market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs for PNH and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs for PNH sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs for PNH market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs for PNH Segment by Company

Alexion Pharmaceuticals

Amgen

Apellis Pharmaceuticals

Roche

Novartis

Samsung Bioepis

Drugs for PNH Segment by Type

Complement Inhibitors

Others

Drugs for PNH Segment by Application

Hospital

Clinic

Other

Drugs for PNH Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for PNH.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs for PNH market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs for PNH manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drugs for PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drugs for PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drugs for PNH Industry Trends Table 2. Drugs for PNH Industry Drivers Table 3. Drugs for PNH Industry Opportunities and Challenges Table 4. Drugs for PNH Industry Restraints Table 5. Global Drugs for PNH Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drugs for PNH Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drugs for PNH Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drugs for PNH Sales Market Share by Manufacturers Table 9. Global Drugs for PNH Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drugs for PNH Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drugs for PNH Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drugs for PNH Manufacturers, Product Type & Application Table 13. Global Drugs for PNH Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs for PNH by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Complement Inhibitors Table 17. Major Manufacturers of Others Table 18. Global Drugs for PNH Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Drugs for PNH Sales by Type (2021-2026) & (K Units) Table 20. Global Drugs for PNH Sales by Type (2027-2032) & (K Units) Table 21. Global Drugs for PNH Sales Market Share by Type (2021-2026) Table 22. Global Drugs for PNH Sales Market Share by Type (2027-2032) Table 23. Global Drugs for PNH Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Drugs for PNH Revenue by Type (2021-2026) & (K Units) Table 25. Global Drugs for PNH Revenue by Type (2027-2032) & (K Units) Table 26. Global Drugs for PNH Revenue Market Share by Type (2021-2026) Table 27. Global Drugs for PNH Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Drugs for PNH Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Drugs for PNH Sales by Application (2021-2026) & (K Units) Table 33. Global Drugs for PNH Sales by Application (2027-2032) & (K Units) Table 34. Global Drugs for PNH Sales Market Share by Application (2021-2026) Table 35. Global Drugs for PNH Sales Market Share by Application (2027-2032) Table 36. Global Drugs for PNH Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Drugs for PNH Revenue by Application (2021-2026) & (K Units) Table 38. Global Drugs for PNH Revenue by Application (2027-2032) & (K Units) Table 39. Global Drugs for PNH Revenue Market Share by Application (2021-2026) Table 40. Global Drugs for PNH Revenue Market Share by Application (2027-2032) Table 41. Global Drugs for PNH Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Drugs for PNH Sales by Region (2021-2026) & (K Units) Table 43. Global Drugs for PNH Sales Market Share by Region (2021-2026) Table 44. Global Drugs for PNH Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Drugs for PNH Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Drugs for PNH Sales by Country (2021-2026) & (K Units) Table 48. North America Drugs for PNH Sales by Country (2027-2032) & (K Units) Table 49. Europe Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Drugs for PNH Sales by Country (2021-2026) & (K Units) Table 51. Europe Drugs for PNH Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Drugs for PNH Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Drugs for PNH Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Drugs for PNH Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Drugs for PNH Sales by Country (2027-2032) & (K Units) Table 58. Global Drugs for PNH Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Drugs for PNH Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Drugs for PNH Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Drugs for PNH Revenue Market Share by Region (2021-2026) Table 62. Global Drugs for PNH Revenue Market Share by Region (2027-2032) Table 63. Alexion Pharmaceuticals Company Information Table 64. Alexion Pharmaceuticals Business Overview Table 65. Alexion Pharmaceuticals Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alexion Pharmaceuticals Drugs for PNH Product Portfolio Table 67. Alexion Pharmaceuticals Recent Development Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Amgen Drugs for PNH Product Portfolio Table 72. Amgen Recent Development Table 73. Apellis Pharmaceuticals Company Information Table 74. Apellis Pharmaceuticals Business Overview Table 75. Apellis Pharmaceuticals Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Apellis Pharmaceuticals Drugs for PNH Product Portfolio Table 77. Apellis Pharmaceuticals Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Roche Drugs for PNH Product Portfolio Table 82. Roche Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis Drugs for PNH Product Portfolio Table 87. Novartis Recent Development Table 88. Samsung Bioepis Company Information Table 89. Samsung Bioepis Business Overview Table 90. Samsung Bioepis Drugs for PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Samsung Bioepis Drugs for PNH Product Portfolio Table 92. Samsung Bioepis Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Drugs for PNH Distributors List Table 96. Drugs for PNH Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Drugs for PNH Product Image Figure 2. Global Drugs for PNH Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for PNH Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs for PNH Sales (2021-2032) & (K Units) Figure 5. Global Drugs for PNH Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drugs for PNH Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Complement Inhibitors Image Figure 9. Others Image Figure 10. Global Drugs for PNH Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Drugs for PNH Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Drugs for PNH Sales Market Share by Type (2021-2032) Figure 13. Global Drugs for PNH Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Drugs for PNH Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Drugs for PNH Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Drugs for PNH Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Drugs for PNH Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drugs for PNH Sales Market Share by Application (2021-2032) Figure 22. Global Drugs for PNH Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Drugs for PNH Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Drugs for PNH Revenue Market Share by Application (2021-2032) Figure 25. North America Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Drugs for PNH Sales Market Share by Country (2021-2032) Figure 27. U.S. Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Drugs for PNH Sales Market Share by Country (2021-2032) Figure 32. Germany Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Drugs for PNH Sales Market Share by Country (2021-2032) Figure 39. China Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Drugs for PNH Sales Market Share by Country (2021-2032) Figure 47. Brazil Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Drugs for PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Drugs for PNH Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Drugs for PNH Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Drugs for PNH Revenue (2021-2032) & (US$ Million) Figure 58. North America Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Drugs for PNH Revenue (2021-2032) & (US$ Million) Figure 60. Europe Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Drugs for PNH Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Drugs for PNH Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Drugs for PNH Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Drugs for PNH Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Inhibitors
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Alexion Pharmaceuticals
  • Amgen
  • Apellis Pharmaceuticals
  • Roche
  • Novartis
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drugs for PNH Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drugs for PNH Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drugs for PNH Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drugs for PNH Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drugs for PNH Market Dynamics
  1. 2.1 Drugs for PNH Industry Trends
  2. 2.2 Drugs for PNH Industry Drivers
  3. 2.3 Drugs for PNH Industry Opportunities and Challenges
  4. 2.4 Drugs for PNH Industry Restraints
3 Drugs for PNH Market by Manufacturers
  1. 3.1 Global Drugs for PNH Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drugs for PNH Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drugs for PNH Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drugs for PNH Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs for PNH Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drugs for PNH Manufacturers, Product Type & Application
  7. 3.7 Global Drugs for PNH Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs for PNH Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs for PNH Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs for PNH Tier 1, Tier 2, and Tier 3
4 Drugs for PNH Market by Type
  1. 4.1 Drugs for PNH Type Introduction
  2. 4.1.1 Complement Inhibitors
  3. 4.1.2 Others
  4. 4.2 Global Drugs for PNH Sales by Type
  5. 4.2.1 Global Drugs for PNH Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Drugs for PNH Sales by Type (2021-2032)
  7. 4.2.3 Global Drugs for PNH Sales Market Share by Type (2021-2032)
  8. 4.3 Global Drugs for PNH Revenue by Type
  9. 4.3.1 Global Drugs for PNH Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Drugs for PNH Revenue by Type (2021-2032)
  11. 4.3.3 Global Drugs for PNH Revenue Market Share by Type (2021-2032)
5 Drugs for PNH Market by Application
  1. 5.1 Drugs for PNH Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Drugs for PNH Sales by Application
  6. 5.2.1 Global Drugs for PNH Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs for PNH Sales by Application (2021-2032)
  8. 5.2.3 Global Drugs for PNH Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drugs for PNH Revenue by Application
  10. 5.3.1 Global Drugs for PNH Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drugs for PNH Revenue by Application (2021-2032)
  12. 5.3.3 Global Drugs for PNH Revenue Market Share by Application (2021-2032)
6 Global Drugs for PNH Sales by Region
  1. 6.1 Global Drugs for PNH Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs for PNH Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs for PNH Sales by Region (2021-2026)
  4. 6.2.2 Global Drugs for PNH Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drugs for PNH Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drugs for PNH Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drugs for PNH Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drugs for PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drugs for PNH Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drugs for PNH Revenue by Region
  1. 7.1 Global Drugs for PNH Revenue by Region
  2. 7.1.1 Global Drugs for PNH Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drugs for PNH Revenue by Region (2021-2026)
  4. 7.1.3 Global Drugs for PNH Revenue by Region (2027-2032)
  5. 7.1.4 Global Drugs for PNH Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drugs for PNH Revenue (2021-2032)
  8. 7.2.2 North America Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drugs for PNH Revenue (2021-2032)
  11. 7.3.2 Europe Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drugs for PNH Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drugs for PNH Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drugs for PNH Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion Pharmaceuticals
  2. 8.1.1 Alexion Pharmaceuticals Company Information
  3. 8.1.2 Alexion Pharmaceuticals Business Overview
  4. 8.1.3 Alexion Pharmaceuticals Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Pharmaceuticals Drugs for PNH Product Portfolio
  6. 8.1.5 Alexion Pharmaceuticals Recent Developments
  7. 8.2 Amgen
  8. 8.2.1 Amgen Company Information
  9. 8.2.2 Amgen Business Overview
  10. 8.2.3 Amgen Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Drugs for PNH Product Portfolio
  12. 8.2.5 Amgen Recent Developments
  13. 8.3 Apellis Pharmaceuticals
  14. 8.3.1 Apellis Pharmaceuticals Company Information
  15. 8.3.2 Apellis Pharmaceuticals Business Overview
  16. 8.3.3 Apellis Pharmaceuticals Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Apellis Pharmaceuticals Drugs for PNH Product Portfolio
  18. 8.3.5 Apellis Pharmaceuticals Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Drugs for PNH Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Drugs for PNH Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Samsung Bioepis
  32. 8.6.1 Samsung Bioepis Company Information
  33. 8.6.2 Samsung Bioepis Business Overview
  34. 8.6.3 Samsung Bioepis Drugs for PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Samsung Bioepis Drugs for PNH Product Portfolio
  36. 8.6.5 Samsung Bioepis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs for PNH Value Chain Analysis
  2. 9.1.1 Drugs for PNH Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs for PNH Production Mode & Process
  6. 9.2 Drugs for PNH Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs for PNH Distributors
  9. 9.2.3 Drugs for PNH Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst